CSPC says NMPA accepts NDA for anbenitamab, albumin-bound docetaxel neoadjuvant breast cancer combo under priority reviewPUBT·11 hours ago01093+0.24%300765+2.86%
Sino Biopharma says China CDE accepts NDA for TQB3909 BCL-2 inhibitor in CLL/SLLPUBT·12 hours ago011770.00%
Sino Biopharma says CDE grants breakthrough therapy status to TQB2102 for HER2-low breast cancerPUBT·1 day ago, 03:35 AM011770.00%
HK Midday: Hang Seng Inches Up 0.3%; Solar Stocks Surge, Alibaba Jumps Over 6%Market Pulse·1 day ago, 01:27 AM06865-1.75%03800+1.47%
Weekly Recap: HA1406 Phase III success and CSPC Innovation H1 profitTradingView·1 day ago, 06:13 PM01093+0.24%300765+2.86%
CSPC Pharma says China clears clinical trial for RSV vaccine candidate SYS 6057PUBT·Jul 31 at 04:56 AM01093+0.24%
CSPC says FDA clears CRB-701 pivotal trial in second-line oropharyngeal cancerPUBT·Jul 29 at 07:34 AMCRBP+5.38%01093+0.24%
Morgan Stanley Remains a Buy on CSPC Pharmaceutical Group (CHJTF)Tip Ranks·Jul 28 at 07:36 PM01093+0.24%
Akeso doses first patient in Phase Ib/II NSCLC trial of HER3 ADC AK138D1 with ivonescimabPUBT·Jul 27 at 09:36 PM09926+2.18%
CSPC PHARMA Marketing Application for Sirolimus for Injection AcceptedAASTOCKS News·Jul 27 at 09:07 PM01093+0.24%
CSPC PHARMA HA1406 Enteric-coated Tablets for Depression Treatment Meet Primary Endpoint in Phase III Clinical TrialAASTOCKS News·Jul 27 at 09:07 PM01093+0.24%
HSI Opens Up 64 pts; LAOPU GOLD Slumps 13% After Positive Profit Alert; XL2CSOPHYNIX, XL2CSOPSMSN Open Down 15%AASTOCKS News·Jul 27 at 08:59 PM01093+0.24%06181-0.38%
CSPC says China NMPA accepts sirolimus albumin-bound injection filing, grants priority reviewPUBT·Jul 27 at 07:58 AM01093+0.24%300765+2.86%
CSPC PHARMA Expects Interim Consolidated Profit of Approximately RMB5.9B-6.2BAASTOCKS News·Jul 27 at 04:44 AM01093+0.24%300765+2.86%
